Search

Displaying results 9601 - 9610 of 10000 in total
  1. Drug

    Gepefrine

    go.drugbank.com/drugs/DB13703
    Experimental

    Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
  2. Drug

    (1R, 2S)-cis 1,2 dihydroxy-1,2-dihydronaphthalene

    go.drugbank.com/drugs/DB08264
    Experimental

    (1R, 2S)-cis 1,2 dihydroxy-1,2-dihydronaphthalene is a solid. This compound belongs to the naphthalenes.

  3. Drug

    Chlorophyll A

    go.drugbank.com/drugs/DB02133
    Experimental

    Categories: Heterocyclic Compounds with 4 or More Rings
  4. Drug

    Acoltremon

    go.drugbank.com/drugs/DB19202
    ApprovedInvestigational

    Acoltremon is under investigation in clinical trial NCT05493111 (A Long-term Safety Study Evaluating the Safety and Systemic Exposure of AR-15512).

    Synonyms: N-(4-methoxyphenyl)-p-menthanecarboxamide, Cyclohexanecarboxamide, n-(4-methoxyphenyl)-5-methyl-2-(1-methylethyl)-, (1r,2s,5r)-
  5. Drug

    Nimotuzumab

    go.drugbank.com/drugs/DB06192
    Investigational

    Products: THERACIM (R)
  6. Drug

    Volociximab

    go.drugbank.com/drugs/DB06647
    Investigational

  7. Drug

    Cucurbita pepo subsp. ovifera whole

    go.drugbank.com/drugs/DB15592
    Approved

    Cucurbita pepo subsp. ovifera whole allergenic extract is used in allergenic testing.

  8. Drug

    Naltalimide

    go.drugbank.com/drugs/DB21082
    Experimental

    Naltalimide is a small molecule drug. Naltalimide has a monoisotopic molecular weight of 472.2 Da.

    Categories: Heterocyclic Compounds with 4 or More Rings
  9. Drug

    Rebaudioside A

    go.drugbank.com/drugs/DB15136
    Investigational

    Rebaudioside A is under investigation in clinical trial NCT03510624 (Acute Effect of Rebaudioside A on Glucose Excursion During an Oral Glucose Tolerance Test in Type 2 Diabetes Mellitus).

  10. Drug

    Ritanserin

    go.drugbank.com/drugs/DB12693
    Investigational

    Ritanserin has been used in trials studying the treatment of Cocaine-Related Disorders.

    Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome